Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Ziprasidone | hsa00020 | Citrate cycle (TCA cycle) | 3.41E-02 | 2 | P50213, O14521 | IDH3A, SDHD | More | | Ziprasidone | hsa00030 | Pentose phosphate pathway | 1.08E-05 | 3 | P60891, P51854, P37837 | PRPS1, TKTL1, TALDO1 | More | | Ziprasidone | hsa00052 | Galactose metabolism | 4.27E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Ziprasidone | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Ziprasidone | hsa00130 | Ubiquinone and other terpenoid-quinone biosynthesis | 1.66E-02 | 1 | Q9BQB6 | VKORC1 | More | | Ziprasidone | hsa00190 | Oxidative phosphorylation | 2.53E-05 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Ziprasidone | hsa00310 | Lysine degradation | 4.57E-02 | 2 | Q96KQ7, Q02809 | EHMT2, PLOD1 | More | | Ziprasidone | hsa00500 | Starch and sucrose metabolism | 1.91E-04 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Ziprasidone | hsa00513 | Various types of N-glycan biosynthesis | 4.83E-02 | 1 | Q9NR34 | MAN1C1 | More | | Ziprasidone | hsa00562 | Inositol phosphate metabolism | 2.00E-02 | 4 | P27987, P19174, P42338, Q02252 | ITPKB, PLCG1, PIK3CB, ALDH6A1 | More | | Ziprasidone | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | | Ziprasidone | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Ziprasidone | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | | Ziprasidone | hsa00600 | Sphingolipid metabolism | 4.77E-02 | 3 | Q9BX95, O14494, P06280 | SGPP1, PLPP1, GLA | More | | Ziprasidone | hsa00630 | Glyoxylate and dicarboxylate metabolism | 1.03E-04 | 2 | P40925, P15104 | MDH1, GLUL | More | | Ziprasidone | hsa00670 | One carbon pool by folate | 1.33E-02 | 2 | P04818, Q99707 | TYMS, MTR | More | | Ziprasidone | hsa00730 | Thiamine metabolism | 1.55E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Ziprasidone | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | | Ziprasidone | hsa00860 | Porphyrin and chlorophyll metabolism | 1.69E-02 | 2 | P36551, P30043 | CPOX, BLVRB | More | | Ziprasidone | hsa00970 | Aminoacyl-tRNA biosynthesis | 2.12E-02 | 1 | P14868 | DARS | More | | Ziprasidone | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-03 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Ziprasidone | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Ziprasidone | hsa00983 | Drug metabolism - other enzymes | 4.77E-02 | 3 | P04183, P32320, P05164 | TK1, CDA, MPO | More | | Ziprasidone | hsa01100 | Metabolic pathways | 4.43E-02 | 23 | Q9NR34, P05089, P32320, P22748, P55809, P06280, Q16875, O43286, O43451, P05186, P24666, Q9HCC0, P33121, P57054, Q9UNP4, Q9BX95, P32321, Q9BPW9, O75911, Q9UHY7, P43490, P46976, P06737 | MAN1C1, ARG1, CDA, CA4, OXCT1, GLA, PFKFB3, B4GALT5, MGAM, ALPL, ACP1, MCCC2, ACSL1, PIGP, ST3GAL5, SGPP1, DCTD, DHRS9, DHRS3, ENOPH1, PBEF1, GYG1, PYGL | More | | Ziprasidone | hsa01200 | Carbon metabolism | 4.32E-02 | 3 | P51854, P37837, P60891 | TKTL1, TALDO1, PRPS1 | More | | Ziprasidone | hsa01230 | Biosynthesis of amino acids | 2.30E-04 | 5 | P51854, P60891, Q99707, P50213, P37837 | TKTL1, PRPS1, MTR, IDH3A, TALDO1 | More | | Ziprasidone | hsa01522 | Endocrine resistance | 1.69E-02 | 3 | Q9UM47, P10415, Q13323 | NOTCH3, BCL2, BIK | More | | Ziprasidone | hsa01524 | Platinum drug resistance | 4.78E-02 | 1 | P31751 | AKT2 | More | | Ziprasidone | hsa02010 | ABC transporters | 2.17E-03 | 3 | P45844, P08183, Q8IZY2 | ABCG1, ABCB1, ABCA7 | More | | Ziprasidone | hsa03008 | Ribosome biogenesis in eukaryotes | 1.88E-02 | 3 | O14980, O60832, Q9BVP2 | XPO1, DKC1, GNL3 | More | | Ziprasidone | hsa03013 | RNA transport | 3.73E-08 | 18 | O14980, P52298, O14893, P61326, Q15287, Q9UBU9, Q7Z3B4, P35658, P63279, Q14152, P55884, O15371, O75822, P78345, P20042, Q14240, P23588, Q9Y6A5 | XPO1, NCBP2, GEMIN2, MAGOH, RNPS1, NXF1, NUP54, NUP214, UBE2I, EIF3A, EIF3B, EIF3D, EIF3J, RPP38, EIF2S2, EIF4A2, EIF4B, TACC3 | More | | Ziprasidone | hsa03020 | RNA polymerase | 3.00E-02 | 3 | P30876, P24928, P62487 | POLR2B, POLR2A, POLR2G | More | | Ziprasidone | hsa03022 | Basal transcription factors | 3.32E-02 | 2 | O00268, Q15544 | TAF4, TAF11 | More | | Ziprasidone | hsa03040 | Spliceosome | 1.59E-06 | 19 | Q14562, O43143, O60508, O14776, P08579, Q15427, O75940, P52298, P38159, P09651, P61978, O75494, Q07955, Q01130, Q13243, P11142, O95777, O43447, P61326 | DHX8, DHX15, CDC40, TCERG1, SNRPB2, SF3B4, SMNDC1, NCBP2, RBMX, HNRNPA1, HNRPK, FUSIP1, SFRS1, SFRS2, SFRS5, HSPA8, LSM8, PPIH, MAGOH | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | 0.888 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | -0.708 | P27707 | DCK | Deoxycytidine kinase | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | -0.726 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | 0.953 | P27707 | DCK | Deoxycytidine kinase | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | -0.816 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | O60508 | CDC40 | Pre-mRNA-processing factor 17 | 0.838 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.837 | P27707 | DCK | Deoxycytidine kinase | O14776 | TCERG1 | Transcription elongation regulator 1 | 0.757 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | 0.788 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.702 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Q15427 | SF3B4 | Splicing factor 3B subunit 4 | 0.71 | P27707 | DCK | Deoxycytidine kinase | O75940 | SMNDC1 | Survival of motor neuron-related-splicing factor 30 | 0.84 | P27707 | DCK | Deoxycytidine kinase | P52298 | NCBP2 | Nuclear cap-binding protein subunit 2 | 0.769 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P38159 | RBMX | RNA-binding motif protein, X chromosome | 0.733 | P27707 | DCK | Deoxycytidine kinase | P09651 | HNRNPA1 | Heterogeneous nuclear ribonucleoprotein A1 | 0.736 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P61978 | HNRPK | Heterogeneous nuclear ribonucleoprotein K | 0.784 | P27707 | DCK | Deoxycytidine kinase | O75494 | FUSIP1 | Serine/arginine-rich splicing factor 10 | 0.824 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.935 | P27707 | DCK | Deoxycytidine kinase | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | -0.804 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.882 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.835 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.886 | P27707 | DCK | Deoxycytidine kinase | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.757 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.746 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.766 | P27707 | DCK | Deoxycytidine kinase | O95777 | LSM8 | U6 snRNA-associated Sm-like protein LSm8 | 0.797 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | -0.761 | P27707 | DCK | Deoxycytidine kinase | P61326 | MAGOH | Protein mago nashi homolog | 0.732 |
| Ziprasidone | hsa03060 | Protein export | 1.20E-03 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | | Ziprasidone | hsa03320 | PPAR signaling pathway | 4.33E-02 | 2 | Q6PCB7, Q9UNU6 | SLC27A1, CYP8B1 | More | | Ziprasidone | hsa03450 | Non-homologous end-joining | 1.02E-03 | 2 | P78527, P13010 | PRKDC, XRCC5 | More | | Ziprasidone | hsa04012 | ErbB signaling pathway | 1.33E-04 | 8 | P21860, P16333, P17252, Q13557, P19174, O14944, P42338, P01106 | ERBB3, NCK1, PRKCA, CAMK2D, PLCG1, EREG, PIK3CB, MYC | More | | Ziprasidone | hsa04014 | Ras signaling pathway | 1.48E-04 | 11 | P31751, P42338, P20827, P49767, Q13009, P17252, P14921, P0DP23, P62873, P50151, P19174 | AKT2, PIK3CB, EFNA1, VEGFC, TIAM1, PRKCA, ETS1, CALM1, GNB1, GNG10, PLCG1 | More | | Ziprasidone | hsa04015 | Rap1 signaling pathway | 1.52E-03 | 9 | P20827, P49767, P11215, Q13009, P42338, P31751, P0DP23, P17252, P19174 | EFNA1, VEGFC, ITGAM, TIAM1, PIK3CB, AKT2, CALM1, PRKCA, PLCG1 | More | | Ziprasidone | hsa04020 | Calcium signaling pathway | 2.34E-04 | 12 | P27987, Q96DU7, P45880, Q13557, P17252, P21860, O15399, P19174, P0DP23, P51828, P23634, P49767 | ITPKB, ITPKC, VDAC2, CAMK2D, PRKCA, ERBB3, GRIN2D, PLCG1, CALM1, ADCY7, ATP2B4, VEGFC | More | | Ziprasidone | hsa04022 | cGMP-PKG signaling pathway | 3.48E-03 | 6 | Q99941, P23634, P31751, P51828, P45880, P0DP23 | CREBL1, ATP2B4, AKT2, ADCY7, VDAC2, CALM1 | More | | Ziprasidone | hsa04024 | cAMP signaling pathway | 4.12E-03 | 7 | P42338, P31751, P0DP23, Q13370, O15399, P25963, Q13009 | PIK3CB, AKT2, CALM1, PDE3B, GRIN2D, NFKBIA, TIAM1 | More | | Ziprasidone | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 3.31E-03 | 8 | P09341, P19875, P25024, P02775, P25025, P47992, Q9UBD3, P14784 | CXCL1, CXCL2, CXCR1, PPBP, CXCR2, XCL1, XCL2, IL2RB | More | | Ziprasidone | hsa04062 | Chemokine signaling pathway | 7.18E-04 | 14 | P25024, P25025, P09341, P19875, P42338, P19174, P62873, P63218, P50151, P43250, Q13009, P14598, P42224, P25963 | CXCR1, CXCR2, CXCL1, CXCL2, PIK3CB, PLCG1, GNB1, GNG5, GNG10, GRK6, TIAM1, NCF1, STAT1, NFKBIA | More | | Ziprasidone | hsa04064 | NF-kappa B signaling pathway | 2.77E-05 | 19 | P10415, P51617, O00463, P14778, P01584, P19174, Q04759, Q9UDY8, Q13077, Q16548, P06239, Q8WV28, P63279, P24522, Q8NHW4, P09341, P19875, Q06643, Q9NQC7 | BCL2, IRAK1, TRAF5, IL1R1, IL1B, PLCG1, PRKCQ, MALT1, TRAF1, BCL2A1, LCK, BLNK, UBE2I, GADD45A, CCL4L2, CXCL1, CXCL2, LTB, CYLD | More | | Ziprasidone | hsa04070 | Phosphatidylinositol signaling system | 2.95E-04 | 8 | P19174, P0DP23, P42338, P23743, Q86XP1, P27987, Q96DU7, P17252 | PLCG1, CALM1, PIK3CB, DGKA, DGKH, ITPKB, ITPKC, PRKCA | More | | Ziprasidone | hsa04071 | Sphingolipid signaling pathway | 2.06E-03 | 7 | P17252, P21453, Q9H228, P01375, Q13362, Q9BX95, P10415 | PRKCA, S1PR1, EDG8, TNF, PPP2R5C, SGPP1, BCL2 | More | | Ziprasidone | hsa04072 | Phospholipase D signaling pathway | 4.48E-02 | 5 | P42338, P43657, P25024, P25025, P19174 | PIK3CB, P2RY5, CXCR1, CXCR2, PLCG1 | More | | Ziprasidone | hsa04080 | Neuroactive ligand-receptor interaction | 1.97E-02 | 5 | P28472, P21453, Q9H228, P21730, P07550 | GABRB3, S1PR1, EDG8, C5AR1, ADRB2 | More | | Ziprasidone | hsa04110 | Cell cycle | 1.21E-03 | 7 | Q9UBD5, P06493, P78527, Q14683, P30304, P33981, P01106 | ORC3, CDK1, PRKDC, SMC1A, CDC25A, TTK, MYC | More | | Ziprasidone | hsa04114 | Oocyte meiosis | 6.23E-03 | 5 | Q9Y6D9, P51812, Q02750, P16298, Q17RY0 | MAD1L1, RPS6KA3, MAP2K1, PPP3CB, CPEB4 | More | | Ziprasidone | hsa04120 | Ubiquitin mediated proteolysis | 3.44E-02 | 4 | Q14145, Q13042, P62837, Q15751 | KEAP1, CDC16, UBE2D2, HERC1 | More | | Ziprasidone | hsa04136 | Autophagy - other | 5.92E-03 | 2 | O94817, Q9H1Y0 | ATG12, ATG5 | More | | Ziprasidone | hsa04141 | Protein processing in endoplasmic reticulum | 3.64E-02 | 5 | Q99941, O75460, P11142, Q9H3Z4, P07900 | CREBL1, ERN1, HSPA8, DNAJC5, HSP90AA1 | More | | Ziprasidone | hsa04142 | Lysosome | 1.46E-02 | 7 | P06865, P22304, P38571, Q13510, P07602, Q9NRA2, P61916 | HEXA, IDS, LIPA, ASAH1, PSAP, SLC17A5, NPC2 | More | | Ziprasidone | hsa04144 | Endocytosis | 2.99E-04 | 11 | P0DMV8, Q9H444, O75351, P62491, Q96B97, Q15438, Q14161, P01889, P10321, P49418, Q9UMY4 | HSPA1A, CHMP4B, VPS4B, RAB11A, SH3KBP1, PSCD1, GIT2, HLA-B, HLA-C, AMPH, SNX12 | More | | Ziprasidone | hsa04145 | Phagosome | 1.11E-04 | 12 | Q15080, P14598, Q13509, P68371, Q13488, P05164, P78380, O60603, P35443, P13765, P01889, P10321 | NCF4, NCF1, TUBB3, TUBB2C, TCIRG1, MPO, OLR1, TLR2, THBS4, HLA-DOB, HLA-B, HLA-C | More | | Ziprasidone | hsa04151 | PI3K-Akt signaling pathway | 1.43E-02 | 12 | P42338, P20827, P49767, P08238, P62873, P50151, P16144, O15335, Q13751, P14784, P01568, P17252 | PIK3CB, EFNA1, VEGFC, HSP90AB1, GNB1, GNG10, ITGB4, CHAD, LAMB3, IL2RB, IFNA21, PRKCA | More | | Ziprasidone | hsa04213 | Longevity regulating pathway - multiple species | 2.70E-03 | 7 | P42338, Q9Y4H2, Q08828, P51828, P0DMV8, P11142, Q13547 | PIK3CB, IRS2, ADCY1, ADCY7, HSPA1A, HSPA8, HDAC1 | More | | Ziprasidone | hsa04217 | Necroptosis | 2.97E-03 | 11 | P01375, P01568, P48023, Q13489, P42224, Q14765, P08238, P15104, Q6FI13, Q99878, O43633 | TNF, IFNA21, FASLG, BIRC3, STAT1, STAT4, HSP90AB1, GLUL, H2AC18; H2AC19, H2AC14, CHMP2A | More | | Ziprasidone | hsa04218 | Cellular senescence | 2.86E-04 | 4 | P31751, P0DP23, P01889, P10321 | AKT2, CALM1, HLA-B, HLA-C | More | | Ziprasidone | hsa04261 | Adrenergic signaling in cardiomyocytes | 3.21E-04 | 10 | P07550, P51828, P22694, P31751, Q99941, P18848, Q13362, P0DP23, Q13557, P23634 | ADRB2, ADCY7, PRKACB, AKT2, CREBL1, ATF4, PPP2R5C, CALM1, CAMK2D, ATP2B4 | More | | Ziprasidone | hsa04270 | Vascular smooth muscle contraction | 6.96E-03 | 6 | P0DP23, Q08828, P51828, P35579, P35749, P35318 | CALM1, ADCY1, ADCY7, MYH9, MYH11, ADM | More | | Ziprasidone | hsa04330 | Notch signaling pathway | 4.34E-02 | 2 | Q92542, P46531 | NCSTN, NOTCH1 | More | | Ziprasidone | hsa04360 | Axon guidance | 2.13E-03 | 7 | P16333, P20827, O95631, P17252, P42338, P23528, P19174 | NCK1, EFNA1, NTN1, PRKCA, PIK3CB, CFL1, PLCG1 | More | | Ziprasidone | hsa04370 | VEGF signaling pathway | 3.67E-05 | 7 | P19174, P16298, P31751, P42338, P17252, Q05397, Q02750 | PLCG1, PPP3CB, AKT2, PIK3CB, PRKCA, PTK2, MAP2K1 | More | | Ziprasidone | hsa04371 | Apelin signaling pathway | 3.23E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | | Ziprasidone | hsa04380 | Osteoclast differentiation | 2.72E-04 | 8 | Q9NQC7, Q9UQC2, Q16539, P31751, P14778, O75015, P01375, Q8N149 | CYLD, GAB2, MAPK14, AKT2, IL1R1, FCGR3B, TNF, LILRA2 | More | | Ziprasidone | hsa04510 | Focal adhesion | 7.77E-03 | 9 | P16144, O75369, P42338, Q15942, P17252, O15335, Q13751, Q13489, P49767 | ITGB4, FLNB, PIK3CB, ZYX, PRKCA, CHAD, LAMB3, BIRC3, VEGFC | More | | Ziprasidone | hsa04514 | Cell adhesion molecules | 3.29E-02 | 2 | P01889, P10321 | HLA-B, HLA-C | More | | Ziprasidone | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | | Ziprasidone | hsa04610 | Complement and coagulation cascades | 2.33E-03 | 1 | P0C0L4 | C4A | More | | Ziprasidone | hsa04612 | Antigen processing and presentation | 9.12E-05 | 8 | Q14953, P26715, P26717, Q13241, P01732, P01889, P10321, P01375 | KIR2DS5, KLRC1, KLRC2, KLRD1, CD8A, HLA-B, HLA-C, TNF | More | | Ziprasidone | hsa04613 | Neutrophil extracellular trap formation | 2.18E-03 | 7 | P04908, Q93077, P62807, O60814, P68431, O43315, Q16539 | H2AC4; H2AC8, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, AQP9, MAPK14 | More | | Ziprasidone | hsa04620 | Toll-like receptor signaling pathway | 4.78E-02 | 1 | P31751 | AKT2 | More | | Ziprasidone | hsa04622 | RIG-I-like receptor signaling pathway | 1.81E-02 | 1 | Q9NQC7 | CYLD | More | | Ziprasidone | hsa04623 | Cytosolic DNA-sensing pathway | 1.35E-03 | 4 | P01584, P01568, P25963, Q8NHW4 | IL1B, IFNA21, NFKBIA, CCL4L2 | More | | Ziprasidone | hsa04625 | C-type lectin receptor signaling pathway | 2.27E-04 | 7 | Q9ULY5, Q9NQC7, P20749, P01375, P31751, P0DP23, Q16539 | CLEC4E, CYLD, BCL3, TNF, AKT2, CALM1, MAPK14 | More | | Ziprasidone | hsa04640 | Hematopoietic cell lineage | 1.37E-02 | 7 | P14778, P27930, P11215, P25063, P07766, P01732, P09564 | IL1R1, IL1R2, ITGAM, CD24, CD3E, CD8A, CD7 | More | | Ziprasidone | hsa04650 | Natural killer cell mediated cytotoxicity | 2.49E-09 | 18 | P16298, P50591, P19174, P01375, P06239, O60880, P20963, Q29983, P10321, P01889, P42338, Q02750, Q13241, P26718, O14931, P26717, Q14953, P26715 | PPP3CB, TNFSF10, PLCG1, TNF, LCK, SH2D1A, CD247, MICA, HLA-C, HLA-B, PIK3CB, MAP2K1, KLRD1, KLRK1, NCR3, KLRC2, KIR2DS5, KLRC1 | More | | Ziprasidone | hsa04657 | IL-17 signaling pathway | 1.46E-04 | 8 | O00463, Q16539, P49841, P09341, P19875, P14780, P80188, P01375 | TRAF5, MAPK14, GSK3B, CXCL1, CXCL2, MMP9, LCN2, TNF | More | | Ziprasidone | hsa04658 | Th1 and Th2 cell differentiation | 1.65E-05 | 10 | Q04759, P07766, P20963, P19174, P06239, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, PLCG1, LCK, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | | Ziprasidone | hsa04659 | Th17 cell differentiation | 3.30E-05 | 14 | P25963, Q04759, P19174, P06239, P42224, P14784, P13765, P14778, P40189, Q9UL17, P23771, P08238, P07766, P20963 | NFKBIA, PRKCQ, PLCG1, LCK, STAT1, IL2RB, HLA-DOB, IL1R1, IL6ST, TBX21, GATA3, HSP90AB1, CD3E, CD247 | More | | Ziprasidone | hsa04660 | T cell receptor signaling pathway | 3.37E-03 | 8 | Q04759, P42338, P19174, P07766, P20963, P01732, Q13191, P06239 | PRKCQ, PIK3CB, PLCG1, CD3E, CD247, CD8A, CBLB, LCK | More | | Ziprasidone | hsa04662 | B cell receptor signaling pathway | 1.60E-04 | 6 | P31751, P42338, P60033, P07948, P21854, Q8N149 | AKT2, PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Ziprasidone | hsa04664 | Fc epsilon RI signaling pathway | 3.91E-05 | 9 | P01375, P31751, Q16539, P42338, P17252, Q9UQC2, P07948, P19174, P09917 | TNF, AKT2, MAPK14, PIK3CB, PRKCA, GAB2, LYN, PLCG1, ALOX5 | More | | Ziprasidone | hsa04666 | Fc gamma R-mediated phagocytosis | 2.60E-03 | 7 | P42338, P19174, P23528, P06396, P14598, P49418, P17252 | PIK3CB, PLCG1, CFL1, GSN, NCF1, AMPH, PRKCA | More | | Ziprasidone | hsa04668 | TNF signaling pathway | 2.70E-04 | 10 | P01375, O00463, Q16539, Q99941, P18848, P19875, P01584, P20749, P14780, O95429 | TNF, TRAF5, MAPK14, CREBL1, ATF4, CXCL2, IL1B, BCL3, MMP9, BAG4 | More | | Ziprasidone | hsa04713 | Circadian entrainment | 1.24E-02 | 5 | O15399, P0DP23, P17252, P62873, P50151 | GRIN2D, CALM1, PRKCA, GNB1, GNG10 | More | | Ziprasidone | hsa04714 | Thermogenesis | 5.21E-03 | 4 | Q16539, P33121, Q16718, O14521 | MAPK14, ACSL1, NDUFA5, SDHD | More | | Ziprasidone | hsa04720 | Long-term potentiation | 2.85E-02 | 3 | P16298, P51812, Q02750 | PPP3CB, RPS6KA3, MAP2K1 | More | | Ziprasidone | hsa04721 | Synaptic vesicle cycle | 1.80E-02 | 2 | Q13488, P31645 | TCIRG1, SLC6A4 | More | | Ziprasidone | hsa04722 | Neurotrophin signaling pathway | 1.61E-04 | 7 | P31751, P49841, O43524, P48023, P51617, P10415, P0DP23 | AKT2, GSK3B, FOXO3, FASLG, IRAK1, BCL2, CALM1 | More | | Ziprasidone | hsa04724 | Glutamatergic synapse | 1.44E-04 | 6 | O15399, P17252, P62873, P63218, P50151, P15104 | GRIN2D, PRKCA, GNB1, GNG5, GNG10, GLUL | More | | Ziprasidone | hsa04725 | Cholinergic synapse | 4.49E-03 | 5 | P17252, P62873, P63218, P50151, P42338 | PRKCA, GNB1, GNG5, GNG10, PIK3CB | More | | Ziprasidone | hsa04726 | Serotonergic synapse | 2.54E-02 | 5 | P17252, P62873, P50151, P33260, P09917 | PRKCA, GNB1, GNG10, CYP2C18, ALOX5 | More | | Ziprasidone | hsa04727 | GABAergic synapse | 5.11E-04 | 5 | P62873, P63218, P50151, P15104, P17252 | GNB1, GNG5, GNG10, GLUL, PRKCA | More | | Ziprasidone | hsa04728 | Dopaminergic synapse | 3.23E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | | Ziprasidone | hsa04740 | Olfactory transduction | 1.36E-04 | 3 | P62873, Q9H255, P0DP23 | GNB1, OR51E2, CALM1 | More | | Ziprasidone | hsa04742 | Taste transduction | 1.01E-02 | 1 | P30939 | HTR1F | More | | Ziprasidone | hsa04744 | Phototransduction | 1.34E-06 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Ziprasidone | hsa04750 | Inflammatory mediator regulation of TRP channels | 8.97E-05 | 10 | P14778, P01584, Q08828, P51828, Q13557, P19174, P42338, P24723, Q04759, P0DP23 | IL1R1, IL1B, ADCY1, ADCY7, CAMK2D, PLCG1, PIK3CB, PRKCH, PRKCQ, CALM1 | More | | Ziprasidone | hsa04910 | Insulin signaling pathway | 9.82E-04 | 2 | P0DP23, P31751 | CALM1, AKT2 | More | | Ziprasidone | hsa04911 | Insulin secretion | 1.48E-02 | 3 | P51828, Q99941, Q13557 | ADCY7, CREBL1, CAMK2D | More | | Ziprasidone | hsa04913 | Ovarian steroidogenesis | 2.54E-02 | 2 | P42330, P22694 | AKR1C3, PRKACB | More | | Ziprasidone | hsa04914 | Progesterone-mediated oocyte maturation | 5.42E-04 | 9 | Q17RY0, P42338, Q13370, Q9UJX4, Q9Y6D9, P30304, P08238, P51812, Q02750 | CPEB4, PIK3CB, PDE3B, ANAPC5, MAD1L1, CDC25A, HSP90AB1, RPS6KA3, MAP2K1 | More | | Ziprasidone | hsa04915 | Estrogen signaling pathway | 5.15E-04 | 9 | Q99941, Q08828, P51828, P31751, P07900, P0DMV8, P11142, P0DP23, Q15788 | CREBL1, ADCY1, ADCY7, AKT2, HSP90AA1, HSPA1A, HSPA8, CALM1, NCOA1 | More | | Ziprasidone | hsa04916 | Melanogenesis | 4.78E-02 | 1 | P0DP23 | CALM1 | More | | Ziprasidone | hsa04917 | Prolactin signaling pathway | 2.41E-02 | 1 | P31751 | AKT2 | More | | Ziprasidone | hsa04920 | Adipocytokine signaling pathway | 4.19E-02 | 1 | P31751 | AKT2 | More | | Ziprasidone | hsa04922 | Glucagon signaling pathway | 1.79E-03 | 2 | P31751, P0DP23 | AKT2, CALM1 | More | | Ziprasidone | hsa04923 | Regulation of lipolysis in adipocytes | 3.88E-03 | 4 | P07550, P42338, Q9Y4H2, P31751 | ADRB2, PIK3CB, IRS2, AKT2 | More | | Ziprasidone | hsa04924 | Renin secretion | 6.02E-03 | 3 | P22694, P07550, P0DP23 | PRKACB, ADRB2, CALM1 | More | | Ziprasidone | hsa04925 | Aldosterone synthesis and secretion | 5.19E-03 | 4 | Q99941, P51828, Q13557, P23634 | CREBL1, ADCY7, CAMK2D, ATP2B4 | More | | Ziprasidone | hsa04926 | Relaxin signaling pathway | 2.34E-05 | 12 | P25963, P42338, P62873, P63218, P50151, P18848, P22694, P49767, P14780, P17252, P30679, P49407 | NFKBIA, PIK3CB, GNB1, GNG5, GNG10, ATF4, PRKACB, VEGFC, MMP9, PRKCA, GNA15, ARRB1 | More | | Ziprasidone | hsa04927 | Cortisol synthesis and secretion | 2.54E-02 | 2 | P18848, P22694 | ATF4, PRKACB | More | | Ziprasidone | hsa04929 | GnRH secretion | 3.61E-03 | 3 | P42338, P31751, P49407 | PIK3CB, AKT2, ARRB1 | More | | Ziprasidone | hsa04932 | Non-alcoholic fatty liver disease | 7.01E-05 | 11 | P01375, P49841, O43521, P48023, O75460, P01584, P13073, P12074, Q16718, O95298, O14521 | TNF, GSK3B, BCL2L11, FASLG, ERN1, IL1B, COX4I1, COX6A1, NDUFA5, NDUFC2, SDHD | More | | Ziprasidone | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 3.43E-02 | 5 | P42224, P42338, P49767, P17252, P19174 | STAT1, PIK3CB, VEGFC, PRKCA, PLCG1 | More | | Ziprasidone | hsa04934 | Cushing syndrome | 3.48E-03 | 4 | Q99941, P51828, O15169, Q13557 | CREBL1, ADCY7, AXIN1, CAMK2D | More | | Ziprasidone | hsa04940 | Type I diabetes mellitus | 4.29E-04 | 4 | P48023, P01889, P10321, P01375 | FASLG, HLA-B, HLA-C, TNF | More | | Ziprasidone | hsa04961 | Endocrine and other factor-regulated calcium reabsorption | 2.68E-02 | 3 | P20020, Q9UEF7, P17252 | ATP2B1, KL, PRKCA | More | | Ziprasidone | hsa04962 | Vasopressin-regulated water reabsorption | 1.80E-02 | 2 | P62491, P46459 | RAB11A, NSF | More | | Ziprasidone | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | | Ziprasidone | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | | Ziprasidone | hsa04970 | Salivary secretion | 5.38E-04 | 6 | P07550, Q08828, P51828, P22694, P0DP23, P49913 | ADRB2, ADCY1, ADCY7, PRKACB, CALM1, CAMP | More | | Ziprasidone | hsa04971 | Gastric acid secretion | 2.57E-03 | 4 | P51828, P15311, P0DP23, Q13557 | ADCY7, VIL2, CALM1, CAMK2D | More | | Ziprasidone | hsa04972 | Pancreatic secretion | 2.68E-02 | 3 | Q14643, P20020, P17252 | ITPR1, ATP2B1, PRKCA | More | | Ziprasidone | hsa04973 | Carbohydrate digestion and absorption | 4.61E-03 | 3 | O43451, P42338, P31751 | MGAM, PIK3CB, AKT2 | More | | Ziprasidone | hsa04975 | Fat digestion and absorption | 4.83E-02 | 1 | O14494 | PLPP1 | More | | Ziprasidone | hsa04976 | Bile secretion | 3.14E-03 | 5 | O43315, Q08828, P51828, P08183, Q14032 | AQP9, ADCY1, ADCY7, ABCB1, BAAT | More | | Ziprasidone | hsa05010 | Alzheimer disease | 7.84E-04 | 10 | Q92542, P05496, P12074, Q00535, O75460, P0DP23, P01584, O15169, P31751, P45880 | NCSTN, ATP5G1, COX6A1, CDK5, ERN1, CALM1, IL1B, AXIN1, AKT2, VDAC2 | More | | Ziprasidone | hsa05016 | Huntington disease | 2.46E-02 | 9 | O95298, P13073, P12074, P24928, P30876, P62487, O75460, P28070, O00232 | NDUFC2, COX4I1, COX6A1, POLR2A, POLR2B, POLR2G, ERN1, PSMB4, PSMD12 | More | | Ziprasidone | hsa05020 | Prion disease | 1.37E-03 | 11 | P01584, P46531, P11142, Q16718, O14521, P05496, P12074, P45880, P49841, Q99941, Q16539 | IL1B, NOTCH1, HSPA8, NDUFA5, SDHD, ATP5G1, COX6A1, VDAC2, GSK3B, CREBL1, MAPK14 | More | | Ziprasidone | hsa05022 | Pathways of neurodegeneration - multiple diseases | 4.25E-03 | 8 | P49841, Q16718, O14521, Q13561, Q16539, Q00535, Q08752, P0DP23 | GSK3B, NDUFA5, SDHD, DCTN2, MAPK14, CDK5, PPID, CALM1 | More | | Ziprasidone | hsa05030 | Cocaine addiction | 4.19E-02 | 1 | Q00535 | CDK5 | More | | Ziprasidone | hsa05031 | Amphetamine addiction | 6.98E-03 | 4 | P0DP23, P22694, P18848, Q13547 | CALM1, PRKACB, ATF4, HDAC1 | More | | Ziprasidone | hsa05032 | Morphine addiction | 1.24E-02 | 5 | P62873, P50151, Q13370, P17252, P43250 | GNB1, GNG10, PDE3B, PRKCA, GRK6 | More | | Ziprasidone | hsa05034 | Alcoholism | 2.89E-03 | 4 | Q93077, P62807, O60814, P68431 | HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Ziprasidone | hsa05110 | Vibrio cholerae infection | 3.15E-02 | 3 | Q13488, P17252, P19174 | TCIRG1, PRKCA, PLCG1 | More | | Ziprasidone | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 1.96E-04 | 6 | Q16539, P09341, P19875, P19174, P25024, P25025 | MAPK14, CXCL1, CXCL2, PLCG1, CXCR1, CXCR2 | More | | Ziprasidone | hsa05132 | Salmonella infection | 9.26E-07 | 16 | P51617, P25963, P08238, Q9UJU2, Q13546, Q13489, P10415, P04406, O75369, Q96A32, O60603, Q9BQS8, Q13561, Q13509, P68371, P49754 | IRAK1, NFKBIA, HSP90AB1, LEF1, RIPK1, BIRC3, BCL2, GAPDH, FLNB, MYLPF, TLR2, FYCO1, DCTN2, TUBB3, TUBB2C, VPS41 | More | | Ziprasidone | hsa05133 | Pertussis | 4.20E-02 | 1 | P0C0L4 | C4A | More | | Ziprasidone | hsa05134 | Legionellosis | 8.80E-04 | 7 | P01584, Q9NR31, P11215, P0DMV8, P11142, P09341, P19875 | IL1B, SAR1A, ITGAM, HSPA1A, HSPA8, CXCL1, CXCL2 | More | | Ziprasidone | hsa05135 | Yersinia infection | 3.29E-02 | 4 | Q05397, P51812, Q02750, Q96JJ3 | PTK2, RPS6KA3, MAP2K1, ELMO2 | More | | Ziprasidone | hsa05140 | Leishmaniasis | 3.44E-05 | 10 | O75015, P14598, P42224, P13765, O60603, P25963, P29350, P49006, Q16539, Q15080 | FCGR3B, NCF1, STAT1, HLA-DOB, TLR2, NFKBIA, PTPN6, MARCKSL1, MAPK14, NCF4 | More | | Ziprasidone | hsa05143 | African trypanosomiasis | 7.50E-04 | 4 | P01375, P69905, P68871, P48023 | TNF, HBA2, HBB, FASLG | More | | Ziprasidone | hsa05144 | Malaria | 1.44E-03 | 5 | P69905, P68871, P01375, P35443, P26718 | HBA2, HBB, TNF, THBS4, KLRK1 | More | | Ziprasidone | hsa05145 | Toxoplasmosis | 3.45E-02 | 6 | P25963, Q13489, P42224, P09917, Q13751, P11142 | NFKBIA, BIRC3, STAT1, ALOX5, LAMB3, HSPA8 | More | | Ziprasidone | hsa05146 | Amoebiasis | 4.70E-06 | 12 | P09341, P19875, P14778, P27930, P01375, O60603, P42338, P11215, P05089, P30679, P22694, P12814 | CXCL1, CXCL2, IL1R1, IL1R2, TNF, TLR2, PIK3CB, ITGAM, ARG1, GNA15, PRKACB, ACTN1 | More | | Ziprasidone | hsa05152 | Tuberculosis | 3.82E-06 | 12 | Q13488, Q15075, P0DP23, P42224, P48382, P25208, O60603, P31751, P10415, P01568, Q9UDY8, P51617 | TCIRG1, EEA1, CALM1, STAT1, RFX5, NFYB, TLR2, AKT2, BCL2, IFNA21, MALT1, IRAK1 | More | | Ziprasidone | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | | Ziprasidone | hsa05162 | Measles | 3.18E-02 | 4 | P23458, P0DMV8, P01584, Q9NP90 | JAK1, HSPA1A, IL1B, RAB9B | More | | Ziprasidone | hsa05163 | Human cytomegalovirus infection | 1.00E-05 | 23 | P31751, P42338, P01375, P25963, P62873, P50151, Q14643, P0DP23, Q8NHW4, Q08828, P51828, P23458, P49841, P14778, P01584, P17252, Q13651, P25025, Q16539, P04637, O00463, P30101, P01568 | AKT2, PIK3CB, TNF, NFKBIA, GNB1, GNG10, ITPR1, CALM1, CCL4L2, ADCY1, ADCY7, JAK1, GSK3B, IL1R1, IL1B, PRKCA, IL10RA, CXCR2, MAPK14, TP53, TRAF5, PDIA3, IFNA21 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 1 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.743 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P01375 | TNF | Tumor necrosis factor | 0.732 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.73 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.837 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.712 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | -0.728 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P0DP23 | CALM1 | Calmodulin-1 | 0.926 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P0DP23 | CALM1 | Calmodulin-1 | 0.822 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P0DP23 | CALM1 | Calmodulin-1 | 0.761 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.802 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.802 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.84 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.834 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.78 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.76 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.778 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P01584 | IL1B | Interleukin-1 beta | 0.799 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P17252 | PRKCA | Protein kinase C alpha type | -0.725 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | 0.799 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.889 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.861 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 1 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.78 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P04637 | TP53 | Cellular tumor antigen p53 | -0.823 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.837 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.734 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P30101 | PDIA3 | Protein disulfide-isomerase A3 | 0.739 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P01568 | IFNA21 | Interferon alpha-21 | -0.868 |
| Ziprasidone | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 1.41E-06 | 17 | P01568, P31751, P42224, P25963, P42338, P40189, P01889, P10321, P62873, P62879, P50151, P19174, P16298, Q02750, Q29983, P0DP23, P0CG47 | IFNA21, AKT2, STAT1, NFKBIA, PIK3CB, IL6ST, HLA-B, HLA-C, GNB1, GNB2, GNG10, PLCG1, PPP3CB, MAP2K1, MICA, CALM1, UBB | More | | Ziprasidone | hsa05168 | Herpes simplex virus 1 infection | 2.01E-05 | 21 | O60603, P25963, P01568, Q05823, P42224, Q07955, Q01130, Q13243, Q13489, P30101, P42338, Q13398, P51522, Q9NR11, Q9HCX3, P17097, Q03923, P52738, O75820, Q9UDV6, P10415 | TLR2, NFKBIA, IFNA21, RNASEL, STAT1, SFRS1, SFRS2, SFRS5, BIRC3, PDIA3, PIK3CB, ZNF211, ZNF83, ZNF302, ZNF304, ZNF7, ZNF85, ZNF140, ZNF189, ZNF212, BCL2 | More | | Ziprasidone | hsa05169 | Epstein-Barr virus infection | 4.67E-03 | 8 | Q13547, P42338, P07948, P01889, P10321, Q13761, O75293, P07766 | HDAC1, PIK3CB, LYN, HLA-B, HLA-C, RUNX3, GADD45B, CD3E | More | | Ziprasidone | hsa05170 | Human immunodeficiency virus 1 infection | 2.07E-07 | 21 | P31751, P42338, P01889, P10321, P62873, P50151, P0DP23, P17252, Q13546, P30101, Q14643, P01568, P51617, P25963, O60603, Q13315, P19174, P23528, Q9NQU5, P10415, Q9Y6Q5 | AKT2, PIK3CB, HLA-B, HLA-C, GNB1, GNG10, CALM1, PRKCA, RIPK1, PDIA3, ITPR1, IFNA21, IRAK1, NFKBIA, TLR2, ATM, PLCG1, CFL1, PAK6, BCL2, AP1M2 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 1 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.743 | Q9H4A3 | WNK1 | Serine/threonine-protein kinase WNK1 | P01889 | HLA-B | HLA class I histocompatibility antigen, B alpha chain | 0.774 | Q9H4A3 | WNK1 | Serine/threonine-protein kinase WNK1 | P10321 | HLA-C | HLA class I histocompatibility antigen, C alpha chain | 0.774 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.837 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.701 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.759 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.712 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P0DP23 | CALM1 | Calmodulin-1 | 0.926 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | P0DP23 | CALM1 | Calmodulin-1 | -0.703 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P0DP23 | CALM1 | Calmodulin-1 | 0.761 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P17252 | PRKCA | Protein kinase C alpha type | -0.725 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | P17252 | PRKCA | Protein kinase C alpha type | 0.769 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | -0.769 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P30101 | PDIA3 | Protein disulfide-isomerase A3 | 0.739 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.823 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P01568 | IFNA21 | Interferon alpha-21 | -0.868 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | P01568 | IFNA21 | Interferon alpha-21 | 0.716 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | 0.741 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | 1 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.73 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | O60603 | TLR2 | Toll-like receptor 2 | -0.862 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | Q13315 | ATM | Serine-protein kinase ATM | 0.758 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.785 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P23528 | CFL1 | Cofilin-1 | -0.853 | Q9H4A3 | WNK1 | Serine/threonine-protein kinase WNK1 | Q9NQU5 | PAK6 | Serine/threonine-protein kinase PAK 6 | 0.75 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.94 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.807 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | Q9Y6Q5 | AP1M2 | AP-1 complex subunit mu-2 | -0.946 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | Q9Y6Q5 | AP1M2 | AP-1 complex subunit mu-2 | -0.814 |
| Ziprasidone | hsa05171 | Coronavirus disease - COVID-19 | 3.30E-02 | 7 | P25963, P42224, P01568, P40189, P42338, P19174, P17252 | NFKBIA, STAT1, IFNA21, IL6ST, PIK3CB, PLCG1, PRKCA | More | | Ziprasidone | hsa05200 | Pathways in cancer | 2.31E-06 | 26 | Q13751, P42338, P08238, P42224, P25963, P19174, Q9UJU2, P17252, P43246, P10826, P14923, P10415, Q13489, Q13077, P49767, P14921, P31751, P62873, P50151, Q9UM47, P78417, O75293, P0DP23, P01568, P14784, P40189 | LAMB3, PIK3CB, HSP90AB1, STAT1, NFKBIA, PLCG1, LEF1, PRKCA, MSH2, RARB, JUP, BCL2, BIRC3, TRAF1, VEGFC, ETS1, AKT2, GNB1, GNG10, NOTCH3, GSTO1, GADD45B, CALM1, IFNA21, IL2RB, IL6ST | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q13751 | LAMB3 | Laminin subunit beta-3 | -0.705 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.743 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.802 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.841 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.73 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.785 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | Q9UJU2 | LEF1 | Lymphoid enhancer-binding factor 1 | 0.768 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P17252 | PRKCA | Protein kinase C alpha type | -0.725 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.925 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P10826 | RARB | Retinoic acid receptor beta | 0.779 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P14923 | JUP | Junction plakoglobin | -0.716 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | P14923 | JUP | Junction plakoglobin | 0.766 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.807 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.747 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | 0.801 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.871 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P14921 | ETS1 | Protein C-ets-1 | 0.731 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 1 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.837 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.759 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.712 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | Q9UM47 | NOTCH3 | Neurogenic locus notch homolog protein 3 | -0.71 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | -0.703 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.919 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P0DP23 | CALM1 | Calmodulin-1 | 0.926 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | P0DP23 | CALM1 | Calmodulin-1 | -0.703 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | P0DP23 | CALM1 | Calmodulin-1 | 0.761 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P01568 | IFNA21 | Interferon alpha-21 | -0.868 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.865 | O95271 | TNKS | Poly [ADP-ribose] polymerase tankyrase-1 | P40189 | IL6ST | Interleukin-6 receptor subunit beta | 0.748 |
| Ziprasidone | hsa05202 | Transcriptional misregulation in cancer | 1.61E-02 | 11 | Q12778, Q15532, Q13315, P14780, P14923, Q13489, Q13077, P35226, P05164, P08246, Q9C0K0 | FOXO1, SS18, ATM, MMP9, JUP, BIRC3, TRAF1, BMI1, MPO, ELA2, BCL11B | More | | Ziprasidone | hsa05203 | Viral carcinogenesis | 8.46E-04 | 6 | Q15283, P06396, P01889, P10321, P62807, O60814 | RASA2, GSN, HLA-B, HLA-C, HIST1H2BC, H2BC12 | More | | Ziprasidone | hsa05204 | Chemical carcinogenesis | 1.48E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Ziprasidone | hsa05205 | Proteoglycans in cancer | 2.92E-04 | 13 | Q13009, Q12955, Q14643, O75369, P14780, P17252, O60603, P01375, P23588, P04628, Q13635, P22694, P08962 | TIAM1, ANK3, ITPR1, FLNB, MMP9, PRKCA, TLR2, TNF, EIF4B, WNT1, PTCH1, PRKACB, CD63 | More | | Ziprasidone | hsa05206 | MicroRNAs in cancer | 2.97E-03 | 6 | P15311, P21860, P61978, P46531, P63279, P22105 | VIL2, ERBB3, HNRPK, NOTCH1, UBE2I, TNXB | More | | Ziprasidone | hsa05211 | Renal cell carcinoma | 4.78E-02 | 1 | P31751 | AKT2 | More | | Ziprasidone | hsa05212 | Pancreatic cancer | 4.78E-02 | 1 | P31751 | AKT2 | More | | Ziprasidone | hsa05213 | Endometrial cancer | 3.60E-02 | 1 | P31751 | AKT2 | More | | Ziprasidone | hsa05214 | Glioma | 6.17E-05 | 6 | P0DP23, P17252, P42338, P31751, P19174, O75293 | CALM1, PRKCA, PIK3CB, AKT2, PLCG1, GADD45B | More | | Ziprasidone | hsa05218 | Melanoma | 3.01E-02 | 1 | P31751 | AKT2 | More | | Ziprasidone | hsa05219 | Bladder cancer | 4.07E-02 | 2 | P14780, P04637 | MMP9, TP53 | More | | Ziprasidone | hsa05220 | Chronic myeloid leukemia | 4.19E-02 | 1 | P31751 | AKT2 | More | | Ziprasidone | hsa05221 | Acute myeloid leukemia | 4.19E-02 | 1 | P31751 | AKT2 | More | | Ziprasidone | hsa05222 | Small cell lung cancer | 1.14E-03 | 7 | P10826, P31751, P42338, Q13751, Q13489, P25963, O75293 | RARB, AKT2, PIK3CB, LAMB3, BIRC3, NFKBIA, GADD45B | More | | Ziprasidone | hsa05223 | Non-small cell lung cancer | 2.50E-04 | 6 | P17252, P31751, P42338, P19174, P10826, O75293 | PRKCA, AKT2, PIK3CB, PLCG1, RARB, GADD45B | More | | Ziprasidone | hsa05224 | Breast cancer | 4.75E-02 | 4 | P49841, Q92837, P04637, P24522 | GSK3B, FRAT1, TP53, GADD45A | More | | Ziprasidone | hsa05226 | Gastric cancer | 3.60E-02 | 1 | P31751 | AKT2 | More | | Ziprasidone | hsa05230 | Central carbon metabolism in cancer | 4.78E-02 | 1 | P31751 | AKT2 | More | | Ziprasidone | hsa05231 | Choline metabolism in cancer | 3.48E-04 | 6 | P42338, Q9Y259, P19174, P23743, P49619, P17252 | PIK3CB, CHKB, PLCG1, DGKA, DGKG, PRKCA | More | | Ziprasidone | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.15E-03 | 11 | P42338, O95267, P19174, P07766, P20963, P09693, P06239, O60603, Q04759, Q16539, P01730 | PIK3CB, RASGRP1, PLCG1, CD3E, CD247, CD3G, LCK, TLR2, PRKCQ, MAPK14, CD4 | More | | Ziprasidone | hsa05310 | Asthma | 2.27E-02 | 2 | P13765, P12724 | HLA-DOB, RNASE3 | More | | Ziprasidone | hsa05320 | Autoimmune thyroid disease | 3.59E-03 | 2 | P01889, P10321 | HLA-B, HLA-C | More | | Ziprasidone | hsa05321 | Inflammatory bowel disease | 1.91E-02 | 3 | P01375, Q14765, Q9UL17 | TNF, STAT4, TBX21 | More | | Ziprasidone | hsa05322 | Systemic lupus erythematosus | 1.31E-04 | 5 | P09871, Q93077, P62807, O60814, P68431 | C1S, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Ziprasidone | hsa05330 | Allograft rejection | 4.29E-04 | 4 | P01889, P10321, P48023, P01375 | HLA-B, HLA-C, FASLG, TNF | More | | Ziprasidone | hsa05332 | Graft-versus-host disease | 2.40E-05 | 6 | P48023, P01889, P10321, P01375, P26715, Q13241 | FASLG, HLA-B, HLA-C, TNF, KLRC1, KLRD1 | More | | Ziprasidone | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | | Ziprasidone | hsa05415 | Diabetic cardiomyopathy | 1.28E-02 | 4 | Q16718, O14521, Q16539, P49841 | NDUFA5, SDHD, MAPK14, GSK3B | More | | Ziprasidone | hsa05416 | Viral myocarditis | 6.58E-03 | 2 | P01889, P10321 | HLA-B, HLA-C | More | | Ziprasidone | hsa05418 | Fluid shear stress and atherosclerosis | 1.27E-05 | 10 | Q16539, P31751, Q14145, P10599, P14780, P01375, P04637, P14778, P27930, P0DP23 | MAPK14, AKT2, KEAP1, TXN, MMP9, TNF, TP53, IL1R1, IL1R2, CALM1 | More | | |